Jim Simons Acutus Medical, Inc. Transaction History

Renaissance Technologies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.17 - $0.31 $3,536 - $6,448	20,800 Added 6.36%	347,800 $65,000
Q4 2023 Feb 13, 2024	BUY	$0.17 - $0.74 $1,972 - $8,584	11,600 Added 3.68%	327,000 $66,000
Q3 2023 Nov 14, 2023	SELL	$0.47 - $0.89 $25,615 - $48,505	-54,500 Reduced 14.73%	315,400 $220,000
Q2 2023 Aug 11, 2023	SELL	$0.66 - $1.02 $16,434 - $25,398	-24,900 Reduced 6.31%	369,900 $328,000
Q1 2023 May 12, 2023	BUY	$0.7 - $1.87 $63,209 - $168,861	90,300 Added 29.66%	394,800 $298,000
Q4 2022 Feb 13, 2023	SELL	$0.62 - $1.15 $60,884 - $112,929	-98,200 Reduced 24.39%	304,500 $350,000
Q3 2022 Nov 14, 2022	BUY	$0.76 - $1.66 $107,236 - $234,226	141,100 Added 53.94%	402,700 $354,000
Q2 2022 Aug 12, 2022	SELL	$0.49 - $1.3 $47,579 - $126,230	-97,100 Reduced 27.07%	261,600 $293,000
Q1 2022 May 13, 2022	BUY	$1.39 - $3.92 $498,592 - $1.41 Million	358,700 New	358,700 $499,000
Q4 2021 Feb 11, 2022	SELL	$3.1 - $8.97 $97,916 - $283,326	-31,586 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.35 - $16.99 $263,743 - $536,646	31,586 New	31,586 $279,000

Ticker AFIB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,370,300
Market Cap $1.42M
Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conv...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.